Plenary Session

Un pódcast de Vinay Prasad, MD MPH

Categorías:

397 Episodo

  1. Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3

    Publicado: 4/10/2023
  2. Great And Crazy Things We Do In Medicine

    Publicado: 20/9/2023
  3. Fixing Cancer Medicine w/ Timothee Olivier

    Publicado: 12/9/2023
  4. Coumadin, ECMO, RCTs and more

    Publicado: 11/9/2023
  5. Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting

    Publicado: 23/8/2023
  6. Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover

    Publicado: 10/7/2023
  7. Testosterone/ Should Scientists Debate/ Mike Joyner

    Publicado: 28/6/2023
  8. Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP

    Publicado: 10/6/2023
  9. ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL

    Publicado: 8/6/2023
  10. OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper

    Publicado: 17/5/2023
  11. Myeloma Roundtable - Manni M. Raj C. VP discuss controversies

    Publicado: 13/5/2023
  12. Mammographic Screening : A complete review of the evidence

    Publicado: 11/5/2023
  13. The Crushing, Cruel Cost of Cancer Drugs - My Lecture

    Publicado: 29/4/2023
  14. Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky

    Publicado: 24/4/2023
  15. Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad

    Publicado: 15/4/2023
  16. Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself

    Publicado: 12/4/2023
  17. Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals

    Publicado: 5/4/2023
  18. 5.47 - Real World Evidence - Keynote Lecture in Denmark

    Publicado: 26/3/2023
  19. 5.46 - What is Science: reflections on the field

    Publicado: 10/3/2023
  20. 5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care

    Publicado: 7/3/2023

3 / 20

A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California, San Francisco. Tweet your feedback to @Plenary_Session or e-mail [email protected].

Visit the podcast's native language site